All news

© Getty Images

Neuraxpharm launches new multiple sclerosis treatment in Europe

By Isabel Cameron

Neuraxpharm Group, a European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, has announced the first launch of BRIUMVI (ublituximab) in Europe for the treatment of adult patients with relapsing multiple...

Follow us